Special Edition Q3, 2022
Feature 66% of Diagnostic Biopsies for Common Skin Cancer can be Avoided Using Michelson Diagnostics’ VivoSight OCT Laser Scanner Major Netherlands study shows that VivoSight OCT is non-inferior to and more cost-effective than punch biopsy This new publication in The Lancet Oncology reports results from the study performed in the Netherlands at three dermatology centres ...
March 2022
Latest News: Two Seminal Recent Articles Confirm Value of OCT for Basal Cell Carcinoma Authors identify the key OCT image characteristics and terminology for evidence-based, practical use in BCC management in clinical routine In the first article, published in JEADV by Fuchs et al.[1], a group of international OCT user experts agreed on a consensus ...
November 2021
Latest News: Early Success Indication of Lengthy Onychomycosis Treatment through OCT Biomarkers Potential for significant cost savings from high predictive value of OCT imaging biomarkers Feature: Mount Sinai Icahn School of Medicine Department of Dermatology Invests in Latest State-of-the-Art Skin Imaging Technologies VivoSight OCT part of a multi-technology approach for skin cancer and beyond “With ...